Clinical Trial

Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 12, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This trial will evaluate the possible benefits and the performance of liquid biopsies in HPV-associated cancer treatment monitoring. This study aims to find a combination of an adequately sensitive and specific sampling method and biomarkers for early risk stratification of disease recurrence.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-03-07; most recent amendment 2026-02-10.
Trial Details
NCT Number NCT05774561
Lead Sponsor The Institute of Molecular and Translational Medicine, Czech Republic
Collaborators: National Institute for Cancer Research, Czech Republic, University Hospital Olomouc
Conditions Cervical Cancer, Cervical Dysplasia, Oropharyngeal Cancer, Human Papillomavirus Infection
Enrollment 480 participants
Start Date 2022-06-01
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-12